Device Knees

Gel-One Cross-Linked Hyaluronate

Payments companies reported to CMS as associated with Gel-One Cross-Linked Hyaluronate. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$77Kassociated payments (2023-2025)
1,236clinicians with associated payments
1company reporting

By year

2023 $19K
2024 $28K
2025 $29K

Payments reported as associated with Gel-One Cross-Linked Hyaluronate, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $26K
Sports Medicine (Family Medicine) $8,913
Physician Assistant $6,536
Sports Medicine (Orthopaedic Surgery) $3,876
Physical Medicine & Rehabilitation $3,368
Surgical $2,719

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Gel-One Cross-Linked Hyaluronate

These are the largest totals companies reported as associated with Gel-One Cross-Linked Hyaluronate. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Irfan Chhipa Egg Harbor Township, NJ Sports Medicine (Family Medicine) $687.49
Sunny Gupta Marlton, NJ Sports Medicine (Family Medicine) $563.84
Branislav Behan Hannibal, MO Orthopaedic Surgery $552.00
Kory Blank Hannibal, MO Orthopaedic Surgery $552.00
Craig Rubenstein Bensalem, PA Sports Medicine (Emergency Medicine) $456.77
John Luksch Glen Mills, PA Sports Medicine (Family Medicine) $454.63
Ryan Pitts Saint Louis, MO Orthopaedic Surgery $451.86
Mitesh Patel Marlton, NJ Sports Medicine (Family Medicine) $451.30
Gary Molk Fairbanks, AK Orthopaedic Surgery $427.73
Danny Giles Duncan, OK Orthopaedic Surgery $418.50

Prescribed Gel-One Cross-Linked Hyaluronate?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.